Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 28, 2014
Jun. 29, 2013
Operating activities    
Net loss $ (1,979) $ (12,910)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 4,620 7,264
Amortization of intangible assets 210 213
Impairment loss on property and equipment 0 4,832
Impairment loss on intangible assets 0 1,245
Deferred income taxes 51 90
Share-based compensation expense 1,005 750
Stock awards issued for non-employee director service 0 21
Amortization of deferred financing costs 41 41
Loss from disposition of assets 2  
Changes in operating assets and liabilities:    
Accounts receivable 1,298 2,087
Inventory 1,808 8,546
Other current assets 161 (323)
Other non-current assets 79 144
Accounts payable and accrued expenses 3,775 (10,783)
Other current liabilities 498 (771)
Other non-current liabilities (161) 490
Net cash provided by operating activities 11,408 936
Investing activities    
Additions to property and equipment (3,036) (4,815)
Proceeds from sale of property and equipment 6  
Cash paid for intangible assets (100)  
Purchases of marketable securities and investments (745)  
Purchases of company-owned life insurance 0 (106)
Net cash used in investing activities (3,875) (4,921)
Financing activities    
Borrowings from revolving loan payable 2,109 10,187
Payments made on revolving loan payable (8,883) (23,140)
Proceeds from sale leaseback transaction 0 9,584
Proceeds from issuance of Series A convertible preferred stock 0 6,017
Payment of issuance costs from Series A convertible preferred stock 0 (822)
Proceeds from issuance of common stock 0 2,235
Payment of issuance costs from common stock 0 (223)
Payments on capital leases (128) (62)
Proceeds from exercise of stock options 218 22
Net cash provided by (used in) financing activities (6,684) 3,798
Effect of exchange rate changes on cash 8 8
Net change in cash and cash equivalents 857 (179)
Cash and cash equivalents, beginning of period 818 1,030
Cash and cash equivalents, end of period 1,675 851
Supplemental disclosure of non-cash investing and financing activities:    
Accrued asset purchases 518 1,046
Unrealized gain on investments 0 2
Supplemental disclosure of cash flow information:    
Cash paid during the period for income taxes 20  
Cash paid during the period for interest $ 468 $ 367